DK1131072T3 - Farmaceutisk kombinationspræparat i fast doseringsform med carvedilol og hydrochlorthiazid - Google Patents

Farmaceutisk kombinationspræparat i fast doseringsform med carvedilol og hydrochlorthiazid

Info

Publication number
DK1131072T3
DK1131072T3 DK99957320T DK99957320T DK1131072T3 DK 1131072 T3 DK1131072 T3 DK 1131072T3 DK 99957320 T DK99957320 T DK 99957320T DK 99957320 T DK99957320 T DK 99957320T DK 1131072 T3 DK1131072 T3 DK 1131072T3
Authority
DK
Denmark
Prior art keywords
carvedilol
hydrochlorothiazide
solid pharmaceutical
pharmaceutical combination
combination formulation
Prior art date
Application number
DK99957320T
Other languages
Danish (da)
English (en)
Inventor
Rudolf Heller
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8233041&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1131072(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK1131072T3 publication Critical patent/DK1131072T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK99957320T 1998-11-27 1999-11-20 Farmaceutisk kombinationspræparat i fast doseringsform med carvedilol og hydrochlorthiazid DK1131072T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98122489 1998-11-27
PCT/EP1999/008972 WO2000032174A2 (en) 1998-11-27 1999-11-20 Pharmaceutical combination preparations of carvedilol and hydrochlorothiazide

Publications (1)

Publication Number Publication Date
DK1131072T3 true DK1131072T3 (da) 2003-08-11

Family

ID=8233041

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99957320T DK1131072T3 (da) 1998-11-27 1999-11-20 Farmaceutisk kombinationspræparat i fast doseringsform med carvedilol og hydrochlorthiazid

Country Status (22)

Country Link
US (3) US6403579B1 (pt)
EP (1) EP1131072B1 (pt)
JP (2) JP2002531395A (pt)
KR (1) KR100421347B1 (pt)
CN (1) CN1184971C (pt)
AR (1) AR020287A1 (pt)
AT (1) ATE238056T1 (pt)
AU (1) AU765977B2 (pt)
BR (1) BR9915610A (pt)
CA (1) CA2352361C (pt)
CO (1) CO5011053A1 (pt)
DE (1) DE69907252T2 (pt)
DK (1) DK1131072T3 (pt)
ES (1) ES2195638T3 (pt)
MY (1) MY121831A (pt)
PE (1) PE20001302A1 (pt)
PT (1) PT1131072E (pt)
TR (3) TR200200982T2 (pt)
TW (1) TWI228414B (pt)
UY (1) UY25821A1 (pt)
WO (1) WO2000032174A2 (pt)
ZA (1) ZA200104280B (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20001302A1 (es) * 1998-11-27 2000-11-30 Hoffmann La Roche Preparaciones de una combinacion farmaceutica que contiene carvedilol e hidroclorotiazida
WO2002065834A2 (en) * 2000-10-24 2002-08-29 Smithkline Beecham Corporation Novel formulations of carvedilol
US20030070584A1 (en) 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
IN191028B (pt) * 2001-05-17 2003-09-13 Sun Pharmaceutical Ind Ltd
US8309118B2 (en) 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
WO2003092622A2 (en) * 2002-04-30 2003-11-13 Sb Pharmco Puerto Rico Inc. Carvedilol monocitrate monohydrate
EP1539140A4 (en) 2002-06-27 2005-12-07 Sb Pharmco Inc CARVEDILOLHYDOBROMID
BR0312102A (pt) * 2002-06-27 2007-05-29 Sb Pharmco Inc sais de fosfato de carvedilol e/ou seus solvatos, composições correspondentes, e/ou métodos de tratamento
EP1562552A1 (en) 2002-11-08 2005-08-17 Egalet A/S Controlled release carvedilol compositions
EP1610767B1 (en) 2003-03-26 2011-01-19 Egalet A/S Morphine controlled release system
WO2004094378A1 (en) * 2003-04-21 2004-11-04 Matrix Laboratories Ltd Process for the preparation of carvedilol form-ii
AU2003272851A1 (en) * 2003-09-26 2005-04-14 Shuyi Zhang Sustained release preparation containing hydrochlorothiazide
JP2007512372A (ja) 2003-11-25 2007-05-17 エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド カルベジロール塩、対応する組成物、送達および／または治療方法
US20050169994A1 (en) * 2003-11-25 2005-08-04 Burke Matthew D. Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
US8734850B2 (en) * 2003-11-25 2014-05-27 Flamel Technologies Oral medicinal product with modified release of at least one active principle in multimicrocapsular form
CN1886132A (zh) * 2003-12-02 2006-12-27 尼科克斯公司 用作降压药的卡维地洛和其它β阻断剂的硝基氧基衍生物
EP2281556A1 (en) * 2005-02-25 2011-02-09 F. Hoffmann-La Roche AG Tablets with improved drugs substance dispersibility
DE602007012692D1 (de) 2006-06-16 2011-04-07 Lek Pharmaceuticals Pharmazeutische zusammensetzung mit hydrochlorothiazid und telmisartan
GB0612540D0 (en) * 2006-06-23 2006-08-02 Novartis Ag Galenical formulations of organic compounds
WO2008114276A1 (en) * 2007-03-16 2008-09-25 Lupin Limited Novel oral controlled release composition of carvedilol
EP2155167A2 (en) 2007-06-04 2010-02-24 Egalet A/S Controlled release pharmaceutical compositions for prolonged effect
NZ594207A (en) 2009-02-06 2013-03-28 Egalet Ltd Immediate release composition resistant to abuse by intake of alcohol
AU2010265213B2 (en) 2009-06-24 2012-08-23 Egalet Ltd. Controlled release formulations
US20130121916A1 (en) * 2010-03-10 2013-05-16 Sergio Baroni Compositions for Colon Lavage and Methods of Making and Using Same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815926A1 (de) 1978-04-13 1979-10-18 Boehringer Mannheim Gmbh Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
FR2643556B1 (fr) * 1989-02-27 1993-03-05 Sanofi Sa Composition pharmaceutique a liberation prolongee d'acide valproique
PL169106B1 (pl) * 1991-01-30 1996-06-28 Wellcome Found Sposób wytwarzania dyspergowalnej w wodzie tabletki PL PL PL PL PL PL PL
DE69222006T2 (de) * 1991-10-30 1998-01-22 Glaxo Group Ltd Mehrschichtzusammensetzungen enthaltend Histamin- oder Serotonin- Antagonisten
TW483763B (en) * 1994-09-02 2002-04-21 Astra Ab Pharmaceutical composition comprising of ramipril and dihydropyridine compound
US5760069A (en) * 1995-02-08 1998-06-02 Boehringer Mannheim Pharmaceuticals Corporation-Smithkline Beecham Corporation Limited Partnership #1 Method of treatment for decreasing mortality resulting from congestive heart failure
FR2752162B1 (fr) * 1996-08-07 1998-11-06 Jouveinal Lab Comprime de maleate de trimebutine pellicule
DE19637082A1 (de) * 1996-09-12 1998-03-19 Boehringer Mannheim Gmbh Schnellzerfallende Pellets
PE20001302A1 (es) * 1998-11-27 2000-11-30 Hoffmann La Roche Preparaciones de una combinacion farmaceutica que contiene carvedilol e hidroclorotiazida

Also Published As

Publication number Publication date
EP1131072B1 (en) 2003-04-23
CN1184971C (zh) 2005-01-19
CN1328460A (zh) 2001-12-26
AU1506500A (en) 2000-06-19
TWI228414B (en) 2005-03-01
KR20010080578A (ko) 2001-08-22
US20020052367A1 (en) 2002-05-02
MY121831A (en) 2006-02-28
CO5011053A1 (es) 2001-02-28
TR200200981T2 (tr) 2002-06-21
US20040087578A1 (en) 2004-05-06
CA2352361C (en) 2007-01-02
ZA200104280B (en) 2002-08-26
KR100421347B1 (ko) 2004-03-06
AU765977B2 (en) 2003-10-09
DE69907252T2 (de) 2004-01-29
ATE238056T1 (de) 2003-05-15
CA2352361A1 (en) 2000-06-08
JP2002531395A (ja) 2002-09-24
TR200101470T2 (tr) 2001-11-21
UY25821A1 (es) 2001-07-31
BR9915610A (pt) 2001-08-14
TR200200982T2 (tr) 2002-06-21
PT1131072E (pt) 2003-08-29
US6403579B1 (en) 2002-06-11
AR020287A1 (es) 2002-05-02
WO2000032174A2 (en) 2000-06-08
WO2000032174A3 (en) 2000-11-16
PE20001302A1 (es) 2000-11-30
DE69907252D1 (de) 2003-05-28
ES2195638T3 (es) 2003-12-01
EP1131072A2 (en) 2001-09-12
JP2007077160A (ja) 2007-03-29

Similar Documents

Publication Publication Date Title
DK1131072T3 (da) Farmaceutisk kombinationspræparat i fast doseringsform med carvedilol og hydrochlorthiazid
DK1767206T3 (da) Faste orale doseringsformer indeholdende valsartan og hydrochlorhiazid
NO20015359D0 (no) Nye medikamentblandinger basert på anti-cholinergisk effektive forbindelser og <beta>-mimetika
NO20021379D0 (no) Benzodiazepin-derivater, fremstilling og anvendelse derav
EE200200251A (et) Uued N-asabitsükloamiidi derivaadid ja nende kasutamine
IS6411A (is) Kaspasa tálmar og notkun þeirra
PT1210380E (pt) Materiais dobraveis para dispositivos oftalmicos e otorrinolaringologicos
EE04452B1 (et) Farmatseutiliselt aktiivne morfolinool ja selle kasutamine
DE60208351D1 (de) Glukopyranosyloxybenzylbenzolderivate und deren medizinische verwendung
DE60230591D1 (de) Glykopyranosyloxypyrazolderivate und deren medizinische verwendung
DE60237580D1 (de) Glykopyranosyloxypyrazolderivate und deren medizinische verwendung
DK1400518T3 (da) Heterocycliske forbindelser og lægemidler
DK1354888T3 (da) Glukopyranosyloxypyrazolderivater og anvendelse deraf i medikamenter
NO20002359L (no) Adenosinderivater og farmasoytisk sammensetning inneholdende derivatene
EE200200341A (et) Asendatud oksasolidinoonid ja nende kasutamine
DK1329456T3 (da) Glucopyranosyloxybenzylbenzenderivater og medicinske sammensætninger indeholdende samme
PT1212317E (pt) Derivados de indole e sua utilizacao no tratamento de osteoporose entre outras aplicacoes
NO20011157D0 (no) Benzenderivater og farmasøytisk anvendelse derav
NO20004277L (no) Indolderivater og farmasøytiske sammensetninger omfattende det samme
NO20010487D0 (no) Disubstituert maleimidforbindelse og farmasöytisk anvendelse herav
DK1200095T3 (da) Lægemiddel med protektiv virkning mod oxidativ-toksiske og især mod cardiotoksiske
NO986174L (no) Triazinderivater og anvendelse derav
DK1025100T3 (da) 3-substituerede tetrahydropyridopyrimidinonderivater, fremstilling og anvendelsen heraf
DE60024476D1 (de) Pedikulizide und veterinärmedizinische zusammensetzungen
NO20001718L (no) Benzen-fusjonerte heterocykliske derivater og anvendelse derav